All News
![](https://pbs.twimg.com/media/D88OyBbUcAAylWe.jpg)
Treating Fatigue in RA. I’m guilty of not addressing 1,2&5 well #EULAR2019 https://t.co/NBvVr4aF1P
Dr Irwin Lim _connectedcare ( View Tweet)
![](https://pbs.twimg.com/media/D88LsN8WkAEb_Og.jpg)
In anti-CCP positive patients with arthralgias but no clinical synovitis, the more Power Doppler signal, the more likely future inflamm arthritis #EULAR2019 THU0072 Paul Emery’s Leeds group @RheumNow https://t.co/QsQ2BV0qKC
David Liew drdavidliew ( View Tweet)
![](https://pbs.twimg.com/media/D88K6x5W4AAzfnL.jpg)
#PhysicalActivity has some evidence for improving rheumatic disease activity & #inflammation
⬇️ESR
⬇️IL-17a
⬇️IL-18
⬇️TNF alpha receptors
⬆️IL-6
via @NoreleeK #EULAR2019
#exercise #arthritis https://t.co/RtARGnbQta
Dr Ai Lyn Tan DrAiLynTan ( View Tweet)
![](https://pbs.twimg.com/media/D873WkoX4AABDNI.jpg)
In this week's issue for #EULAR2019: Upadacitinib as monotherapy in patients with active #rheumatoidarthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study https://t.co/hyAKuBPVtJ https://t.co/xSnHZFZtKo
Links:
The Lancet TheLancet ( View Tweet)
![](https://pbs.twimg.com/profile_images/741158167237775360/Umv4cQ26.jpg)
Do you really believe that @_connectedcare ? https://t.co/QmGFTOLCyK
Dr Philip Robinson philipcrobinson ( View Tweet)
![](https://pbs.twimg.com/media/D83KYyMXsAU3flV.jpg)
We’re getting closer to something we can use.....RT @sylba2308: New targets in #osteoarthritis #EULAR2019 https://t.co/sBEkeJuPza
Dr Irwin Lim _connectedcare ( View Tweet)
![](https://pbs.twimg.com/media/D88D-DoW4AA5ky7.jpg)
Contemporary epidemiology of gout in the UK population.. #EULAR2019 @KeeleUniversity #Gout https://t.co/lcNz84InBL
Dr.Martínez MtzReuma ( View Tweet)
![](https://pbs.twimg.com/media/D88Ec6zXoAEhidz.jpg)
Interesting politic that may exist between the 2 authoritative bodies on axial vs peripheral SpA #eular2019 https://t.co/Ksc4C3iELj
Alberta Hoi tuna0sashimi ( View Tweet)
![](https://pbs.twimg.com/profile_images/741158167237775360/Umv4cQ26.jpg)
I worry about really long term use and atypical fractures Irwin, pretty serious consideration after 7 years of BP therapy. https://t.co/RUQeLbpZjm
Dr Philip Robinson philipcrobinson ( View Tweet)
![](https://pbs.twimg.com/media/D88FiumW4AEC0vk.jpg)
@_connectedcare @LaurentGrange I am just curious to see their names but really challenging to remember them. https://t.co/TuKQNcfu5m
Alberta Hoi tuna0sashimi ( View Tweet)
![](https://pbs.twimg.com/media/D88GJKkXYAAgUDR.jpg)
Gout and associated comorbidities - Edward Roddy @KeeleUniversity #EULAR2019 https://t.co/KC3ITm0FKZ
Dr.Martínez MtzReuma ( View Tweet)
![](https://pbs.twimg.com/media/D87tkFcXUAA2_CO.jpg)
Multitarget therapy for #Lupus under development
👉🏻 Fenebrutinib @Roche
👉🏻 Evobrutinib @MerckHealthcare
👉🏻 Spleen Kinase Inhibitors @GileadSciences @RigelPharma
👉🏻 Encoding transcription factors @Celgene
👉🏻 JAK/Tyk Inhibitors @PfizerCongress @LillyRheumEU @bmsnews @GSK
#EULAR2019 https://t.co/CeUwIQaCx4
Juan Ovalles, MD, PhD DrJuanOvalles ( View Tweet)
![](https://pbs.twimg.com/media/D88G0L4WwAA55ek.jpg)
Gout management in CKD & allopurinol in the renal function.. - Roddy @KeeleUniversity #EULAR2019 https://t.co/B9TP4jHb4k
Dr.Martínez MtzReuma ( View Tweet)
![](https://pbs.twimg.com/profile_images/1256991531959009280/HZ-nXZcj.jpg)
Links:
Dr Suleman Khan Rheumatologistt ( View Tweet)
![](https://pbs.twimg.com/media/D87dhwEXUAAJATX.jpg)
Marc de Meulemeester presents finding of #gout survey of 1100 patients across Europe at #EULAR2019. Significant burden of disease: 10% of patients had lost their job/retired due to gout, ability to walk, sleep, mental health & sex lives affected. https://t.co/uAcoChIBhV
Arthritis Ireland Arthritisie ( View Tweet)
![](https://pbs.twimg.com/media/D87r7ifXsAE660n.jpg)
Ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic #lupus erythematosus - a between group difference of 29%. Article in @TheLancet https://t.co/kic3xAfHcE #EULAR2019 #LancetRheumatology https://t.co/Wizel4nnSk
Links:
The Lancet Rheumatology TheLancetRheum ( View Tweet)
![](https://pbs.twimg.com/media/D87hZgYW4AA6_3s.jpg)
Predictors of severe cranial ischemic complications in Giant cell arteritis. 20%GPC patients presented/developed severe vision manifestations and/or ischemic stroke.. age and jaw claudication predicted severe cranial ischemic complications ~ Alojzija Hocevar #eular2019 https://t.co/PSaRfD5kSa
Dr.Martínez MtzReuma ( View Tweet)
![](https://pbs.twimg.com/profile_images/990351876804591616/xFG36pY3.jpg)
GIACTA update #eular2019
RT @drdavidliew: To recall, part 1 52 wks, TCZ vs placebo & wean prednisolone. By end 52 wks, defined themselves by their response categories: remission no treatment, remission on treatment, active on treatment. What happens when IL-6 inhibition stops?
Dr Irwin Lim _connectedcare ( View Tweet)
![](https://pbs.twimg.com/media/D88KEHCXUAAmd_V.jpg)
IL-17A and IL-17F are secreted by entheseal T cells, and both synergize with TNF to recruit IL-17+ T cells to sites of inflammation. Timely translational data for bimekizumab #EULAR2019 THU0013 from Dennis McGonagle’s Leeds group @RheumNow https://t.co/27DMCBj1VV
David Liew drdavidliew ( View Tweet)
![](https://pbs.twimg.com/media/D88J06cXoAAX1Dt.jpg)
#Comorditiy is common in #gout & distinct #clusters form. #allopurinol can be safely be used in #ckd at higher than historically suggested doses. Uncertainty remains around association between gout & #neurodegeneration. #EULAR2019 @GoutEducation @GoutandYou @PCSciences @elinlowri https://t.co/7z6ZkbnZRZ
Dr James Prior DrJamesPrior ( View Tweet)